Alteplase does not appear to benefit patients with mild acute ischemic stroke presenting with initially minor neurologic deficits. The findings, from the prematurely terminated PRISMS trial, support current practice and should help reassure clinicians in managing this sub-group of stroke patients with a low NIH Stroke Scale score and non-disabling symptoms. The data, from the ...
Stick with aspirin in mild stroke with non-disabling symptoms
By Mardi Chapman
11 Jul 2018